Literature DB >> 9427303

In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells.

N Klöcker1, F Bräunling, S Isenmann, M Bähr.   

Abstract

The identification of neurotrophic factors ameliorating secondary neuronal death in the mammalian CNS has raised hopes for improved treatment strategies in neurodegenerative diseases, CNS trauma and ischemia. Glial cell-line derived neurotrophic factor (GDNF) has potent neuroprotective properties in both the CNS and PNS. We sought to investigate whether GDNF exerts survival promoting effects on axotomized retinal ganglion cells (RGCs) in the adult rat in vivo. Transection of the optic nerve induces delayed retrograde death of approximately 85% of RGCs within 14 days. Intraocular GDNF rescued 21% of the RGCs which would otherwise have died after axotomy (34% of the normal control population), thereby extending the group of neuronal populations responsive to GDNF.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427303     DOI: 10.1097/00001756-199711100-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  18 in total

1.  Axotomy-induced early down-regulation of POU-IV class transcription factors Brn-3a and Brn-3b in retinal ganglion cells.

Authors:  Jochen H Weishaupt; Nikolaj Klöcker; Mathias Bähr
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Amacrine cell gene expression and survival signaling: differences from neighboring retinal ganglion cells.

Authors:  Noelia J Kunzevitzky; Monica V Almeida; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-05       Impact factor: 4.799

3.  Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo.

Authors:  R Diem; R Meyer; J H Weishaupt; M Bahr
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

Review 4.  Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.

Authors:  Karine Evangelho; Maria Mogilevskaya; Monica Losada-Barragan; Jeinny Karina Vargas-Sanchez
Journal:  Int Ophthalmol       Date:  2017-12-30       Impact factor: 2.031

5.  Hydrocortisone stimulates neurite outgrowth from mouse retinal explants by modulating macroglial activity.

Authors:  Kimberly A Toops; Cynthia Berlinicke; Donald J Zack; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-24       Impact factor: 4.799

6.  Both the neuronal and inducible isoforms contribute to upregulation of retinal nitric oxide synthase activity by brain-derived neurotrophic factor.

Authors:  N Klöcker; P Kermer; M Gleichmann; M Weller; M Bähr
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 7.  Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation.

Authors:  D Ellenberg; J Shi; S Jain; J-H Chang; H Ripps; S Brady; E R Melhem; F Lakkis; A Adamis; D-F Chen; R Ellis-Behnke; R S Langer; S M Strittmatter; D T Azar
Journal:  Br J Ophthalmol       Date:  2009-03-13       Impact factor: 4.638

8.  Effects of crystallin-β-b2 on stressed RPE in vitro and in vivo.

Authors:  Michael R R Böhm; Harutyun Melkonyan; Patrick Oellers; Solon Thanos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-17       Impact factor: 3.117

Review 9.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

Review 10.  Gene therapy targeting glaucoma: where are we?

Authors:  Xuyang Liu; Carol A Rasmussen; B'ann T Gabelt; Curtis R Brandt; Paul L Kaufman
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.